Publication | Open Access

Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study

Metastatic Melanoma SurvivorsQuality Of LifeOncologyPsychiatryHealth-related QualityCancer ManagementNeurocognitive FunctionPatient-reported OutcomeMental HealthCancer TreatmentTerminal IllnessMedicineRadiation OncologyHealth Sciences